Work

Technology assessment report commissioned by the HTA Programme on behalf of The National Institute for Clinical Excellence The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation (review of Guidance No. 33) Addendum: Economic evaluation of irinotecan and oxaliplatin for the treatment of advanced colorectal cancer